Pleasant View Sleep Disorders Ctr, Llc Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 254 Ren Mar Dr, Suite 200, Pleasant View, TN 37146 Phone: 615-746-4533 Fax: 615-746-4536 |
5 Star Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2475 Highway 49 E, Pleasant View, TN 37146 Phone: 615-746-2929 Fax: 615-746-9998 |
Pleasant View Dental Spa Pllc. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6312 Highway 41a, Suite 100, Pleasant View, TN 37146 Phone: 615-746-3700 Fax: 615-746-3745 |
Children's Dental Health Center - Pleasent View Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6509 Highway 41a, Suite B, Pleasant View, TN 37146 Phone: 615-256-7543 Fax: 615-256-8895 |
Pleasant View Smiles Dentist Medicare: Not Enrolled in Medicare Practice Location: 6312 Highway 41a Ste 100, Pleasant View, TN 37146 Phone: 615-746-3700 |
Dental Specialty Education, Inc.- Pleasant View Dentist Medicare: Not Enrolled in Medicare Practice Location: 6509 Highway 41a, Suite A, Pleasant View, TN 37146 Phone: 615-247-7100 Fax: 615-247-7052 |
News Archive
Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.
Two genetics researchers from the Johns Hopkins University School of Medicine have been awarded prestigious honorary Doctor of Medicine degrees by European scientific institutions.
We all perhaps know the feeling of mental exhaustion, but what does it mean physiologically to have mental fatigue? A new study carried out using brain scans could help scientists uncover the neurobiological mechanisms underlying mental fatigue.
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, 2-hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas, the most common type of brain cancers.
› Verified 1 days ago